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19th CardioVascular Summit: TCTAP 2014development and the introduction of the echo or IVUS guided EVT. But now this is still
challenging. In the diagnosis of peripheral artery disease, duplex ultrasonography is
noninvasive, simple and usefulness, but it was impossible to assess the lesion morphology.
Elastography is an ultrasonographic method that has been examined as a diagnostic tool
for breast lesions. We applied this method to hardness measurement of CTO lesions by
our original method. Our aim was to investigate the usefulness of the ultrasonography
(US) “vascular elastography (VE)” in EVT for long CTO lesions of SFA.
Methods: In 1274 consecutive cases which underwent EVT between April 2010 and
May 2013, we focused on 57 cases of EVT for long CTO of femoropopliteal arteries,
which CTO length was more than 150mm. We assessed the CTO lesions by duplex
US and “VE” about lesion hardness with our original methods before procedure. US
was performed with 8 MHz linear transducer (Aprio XG/500, TOSHIBA, Japan), and
off-line analysis of “VE” was performed with elasto-Q (TOSHIBA, Japan). We
originally categorized into ﬁve types by original VE score. The ratio of hard
appearance portion (VE score 0-1) to CTO (H/T ratio) was evaluated. Comparing
investigation about procedure results was performed between hard group (H group:
hard portion>20%) and non-hard group (NH group: hard portion<20%). In EVT,
guide wire was penetrated with US guided from body surface without ﬂuoroscopy.
Results: We could assess elastogram of target CTO lesions in all cases (H group: 27
cases, S group: 30 cases). No signiﬁcant difference was detected in CTO lesion length
(H: 28.96.8mm, S: 26.64.7mm). Hard portions were detected in CTO lesions (H:
10.26.9mm, H/T ratio 32.515.8% vs. S: 1.81.8mm, H/T ratio 7.36.6%;
p<0.001). Operation time in H group was longer than S group (H: 248.0115.1min
vs. S: 142.942.1min; p¼0.01). Success rate was H: 92.6% vs. S: 100%. No sig-
niﬁcant difference was detected in case of retrograde approach from popliteal artery
(H: 29.6%, S: 10.0%). Retrograde approach was needed in only 17 cases which distal
site of CTO was VE score 0 to 2 (VE score 0-2: 29.8% vs. 3-4: 0%; p<0.01).Cases in
S group could be penetrated with hydrocoat soft guidewire (12.1% vs. 65.2%;
p<0.001). In 11 cases, CTO site was all soft appearance as VE score 3 to 4. A hy-
drophilic soft guide wire could pass the lesion easily.
Conclusion: “Vascular Elastography” might be able to predict the difﬁculty of EVT,
useful when we decide strategies and selections of device because we could assess
the vascular morphology noninvasively before procedure. VE could detect the hard
plaque which difﬁcultly penetrated without calciﬁcation.
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A Comparison Between Contrast Assisted Carbon Dioxide Digital Subtraction
and Pure Carbon Dioxide Digital Subtraction Angiography in Endovascular
Therapy: A Sub-study of the CO2 Angiography Registry (a Prospective
Multicenter Trial)
Ryota Fukuoka1, Yoshiaki Shintani1, Masahiko Fujihara2
1Shin-Koga Hospital Cardiovascular Center, Kurume, Japan, 2Kishiwada Tokushukai
Hospital, Kishiwada, Japan
Background: The iodinated contrast volume can cause an exacerbation of the renal
function. Previous report has demonstrated CO2 guided angioplasty to effectively
reduce the amount of contrast volume. However, in general CO2 angiography, the image
quality tends to be poor, especially in the renal artery. As a result of such poor images, the
procedure time when performing CO2 angiography thus becomes prolonged. We
therefore evaluated the efﬁcacy and safety of the contrast media used when performing
endovascular therapy with CO2 digital subtraction angiography in CKD patients.
Methods: A prospective multicenter registry was performed for CO2 guided angi-
ography of the renal artery or iliofemoral angioplasty. Patients with estimated an
Glomerular Filtration Rate ( eGFR) <60ml/min/1.73m2 were recruited for this study.
The patients in the CO2 registry were divided into either the Co2 only group or the
Co2+contrast group. Comparisons were made between each group, regarding the
procedures and any serial changes in the renal function. An exacerbation of the renal
function was thus deﬁned as a 25% decline in the creatinine level at three months We
evaluated the efﬁcacy and safety of the contrast media used for endovascular therapy
with CO2 Digital subtraction angiography in CKD patients.
Results: A total of 92 patients were divided into the CO2 only group (N¼37) and the
CO2+contrast group (N¼55). The age was 75.27.3 years old in the CO2 only group
and 75.28.61 years old in the CO2+contrast group. There were 94 target lesions in
the CO2 only group (aorto-iliac arteries: 27, femoro-popliteal arteries: 54, renal ar-
teries: 13), while there were 86 lesions in the Co2+contrast group (aorto-iliac arteries:
15, femoro-popliteal arteries: 58, renal arteries: 13). The contrast volume in the CO2
only group was 0 ml, while it was 24.916.9 ml in the CO2+contrast group (P<0.01).
The procedure time was 25.019.1 min in the CO2 only group, and 20.815.1 min in
the CO2+contrast group (P¼ns). The CO2 dose in the CO2 only group was
333.1143.6 ml, 235.3 142.0 ml in the CO2+contrast group (P<0.01). A decline in
the renal function was observed at three months in 1 patient in the CO2 only group
and in 4 patients in the CO2 contrast group (P¼Ns). According to a univariate
analysis, the only predictor of a decline in the kidney function was only the serum
creatinine level that was obtained before intervention.
Conclusion: A small contrast volume used during CO2 angiography for endovascular
therapy therefore was not found to exacerbate the renal function at three months. The
only predictor of a decline in the kidney function was therefore determined to be the
serum creatinine level that was obtained before intervention.JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/ORATCTAP A-103
Impact of Pulse Pressure on 12-month Angiographic and Clinical Outcomes
Following Endovascular Intervention in Patients with Critical Limb Ischemia
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Hong Seog Seo, Dong Joo Oh
Korea University Guro Hospital, Seoul, Korea (Republic of)
Background: Pulse pressure (PP) is one of strong predictors of arterial stiffness and
atherosclerosis. It has been reported that a 10 mmHg increase in PP increased the risk
of major cardiovascular complications and mortality by nearly 20%. However, clinical
signiﬁcance of wide PP difference deﬁned as PP  100mmHg following endovascular
intervention (EVT) for patients with critical limb ischemia (CLI) are not clariﬁed yet.
Methods: A total 286 consecutive patients with CLI for EVT from August 2004
to November 2012 were enrolled for this study. PP was calculated by subtracting the
diastolic pressure from the systolic pressure of a brachial artery. A total 52 patients
(18.2%) had PP  100mmHg. We compared the angiographic and clinical outcomes
of patients with PP  100mmHg to those with PP < 100mmHg at 12-months.
Results: The baseline characteristics are well balanced between the two groups except
Ankle brachial index which was lower in the PP  100mmHg group (Table 1). At 12
months, although the incidence of mortality, target lesion revascularization (TLR),
target extremity revascularization (TER), and limb salvage rate were similar between
the two groups, the patients who had PP  100mmHg had higher incidence of binary
restenosis and showed lower primary patency and secondary patency than those who
had PP <100mmHg (Table 2).
Conclusion: Higher PP was associated with lower ABI, higher restenosis rate and
lower patency at 1 year, suggesting more intensive medical therapy with close clinical
follow up will be required for patients with PP  100mmHg following EVT.TCTAP A-104
Real World Clinical Outcome of Drug-eluting Stent Implantation in
Femoropopliteal Lesions
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Saiseikai Yokohama-city Eastern Hospital, Yokohama, Japan
Background: To investigate the clinical outcomes of endovascular therapy (EVT)
with drug eluting stents (DES) for all-comers with femoropopliteal (FP) disease.
Methods: This is a single center, retrospective study. Between July 2012 and April
2013, 83 patients (54 men; mean age 74 years) underwent stent implantation for 115
FP lesions in 102 limbs with Cook Medical’s self-expanding Zilver PTX paclitaxel-
eluting nitinol stent. 42 patients(51%) were diabetic and 20 patients(24%) were on
hemodialysis. 29 patients(28%) had critical limb ischemia (CLI). 44% were TASC C
or D (C,18%; D,26%) Mean lesion length and diameter were 13694 mm and
5.71.0 mm. We evaluated the clinical outcomes. Restenosis was assessed by either
duplex ultrasound or angiography. Sub-analysis for the risk factor of restenosis was
also performed.
Results: Patients were followed up for 63 months. Restenosis occurred in 10 lesions
(8.7%). Occlusion occurred in 6 lesions (5.2%). The incidence of target lesion revas-
cularization was 5.2%. Major adverse limb events occurred in 7 cases (6.9%) (FP
bypass grafting, 2 cases; major amputation, 5 cases). No stent thrombosis occurred in 90
days. 2 major complication (1 distal embolism and 1 hematoma requiring bloodL/Peripheral Vascular Intervention (Non-carotid, Non-neurovascular) S29
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19th CardioVascular Summit: TCTAP 2014transfusion) occurred in the procedure. The rate of all-cause death was 7.2%. Restenotic
lesion (p¼0.004), chronic total occlusion (p¼0.03), TASC type C or D lesion
(p¼0.009) and smaller stent diameter (p¼0.02) have an effect on restenosis.
Table below shows the correlation between these parameters and restenosis.
Conclusion: FP stenting with DES yielded acceptable outcomes in short-term.TCTAP A-105
Comparison on Vascular Response Between Bare-metal Nitinol
Stent Implantation and Paclitaxel-eluting Nitinol Stent Implantation in the
Superﬁcial Femoral Artery Lesion Assessed by Intravascular Ultrasound
Kojiro Miki, Kenichi Fujii, Masashi Fukunaga, Masashi Nishimura,
Tetsuo Horimatsu, Tohru Masuyama
Hyogo College of Medicine, Nishinomiya, Japan
Background: Although previous intravascular ultrasound (IVUS) studies reported
that drug-eluting stent (DES) have successfully decreased in-stent restenosis (ISR) by
inhibiting neointimal hyperplasia (NIH) in the coronary artery lesion, no IVUS data
for NIH after DES implantation in the superﬁcial femoral artery (SFA) has been
published.
Methods:We analyzed 38 SFA lesions that underwent endovascular treatment (EVT)
with self-expanding bare-metal nitinol stents (25 lesions, BMS group) or paclitaxel-
eluting nitinol stents (13 lesions, PES group). At 6 months after EVT, follow-up
angiography and IVUS examination were performed in all cases. The serial IVUS
volumetric analysis was performed after stent deployment and at follow-up. Vessel,
stent, lumen, plaque and neointimal volumes were calculated using Simpson’s rule.
Mean stent, lumen and neointimal areas were computed as the volume divided by the
stent length. Mean late lumen area loss was deﬁned as mean lumen area immediately
after initial deployment - mean lumen area at follow-up. The primary end point of this
study was mean late lumen loss at 6-month follow-up. The secondary end point was
angiography-deﬁned ISR rate at 6 months.
Results: The mean follow-up period was 189  39 days. Mean neointimal area was
smaller in PES group compared to BMS group (3.3  1.0 mm2 vs. 10.2  4.1 mm2,
p<0.001, ﬁgure). Mean late lumen loss was signiﬁcantly lower in PES group
compared to BMS group (-2.3  3.7 mm2 vs. 2.1  4.7 mm2, p<0.05, ﬁgure).
Angiography-deﬁned ISR rate was similar between two groups.
Conclusion: EVT with DES in the SFA lesions might decrease NIH that associated
with ISR.S30 JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP AbstractsTCTAP A-106
Effects of Percutaneous Transluminal Renal Angioplasty on Blood Pressure
Evaluated with 24-hour Monitoring
Kentaro Jujo, Ahsung Kim, Issei Ishida, Yuki Suzuki, Katsumi Saito
Nishiarai Heart Center Hospital, Tokyo, Japan
Background: Percutaneous transluminal renal angioplasty (PTRA) improves patency
in atherosclerotic renal artery stenosis (ARAS). However, OFFICE blood pressure
(BP) improvement as primary purpose was achieved in only 20-40% of patients
performed PTRA. The purpose of this study was to clarify the effects of PTRA on BP
response by 24-hour BP monitoring, and identify preoperative features that predict a
sufﬁcient BP response to PTRA.
Methods: Out of 1191 consecutive patients underwent coronary angiography, 505
patients with hypertension were followed by abdominal aortography for etiological
screening of hypertension in a single cardiovascular center from Jan 2010 till Oct
2012. Among patients with angiographically signiﬁcant stenosis, 30 patients with
more than 20 mmHg translesional pressure gradient at renal artery under hyperemic
condition were underwent PTRA. Ambulatory blood pressure monitoring (ABPM)
was performed before and 1 month after PTRA, and patients were categorized as
‘Responders’ depending on average systolic BP decrease more than 10 mmHg.
Physiological, echorenographic and hormonal parameters were retrospectively
compared between Responders and Non-responders.
Results: There was no signiﬁcant difference in BP at admission between 13 Responders
and 17 Non-responders (systolic, 148  18 vs. 145  17, p¼0.62; diastolic, 70  9.3
vs. 68  14, p¼0.62; mean, 96  7.8 vs. 93  14 mmHg, p¼0.55). Baseline BP on
ABPM was signiﬁcantly high in Responders (systolic, 148  10 vs. 127  16, p<0.01;
diastolic, 80 7.2 vs. 71 8.3, p<0.01; mean, 102 6.4 vs. 89 10 mmHg, p<0.01).
Even BP 2 days after PTRA was not different between the groups (systolic, 130  19
vs. 133  17, p¼0.68; Δsystolic, -19  17 vs. -12  15, p¼0.31), Responders achieved
16 6.7 mmHg decrease in systolic BP on ABPM 1 month after PTRA, did not in Non-
responders (-6.9  13 mmHg, p<0.01). On clinical backgrounds and prehospital
medication, there was no statistical difference. Also, translesional pressure gradient at
hyperemic condition detected by pressure wire was not statistically different between the
groups (36  32 vs. 30  25 mmHg, p¼0.60). In terms of echorenographic parameters,
acceleration time (AT) at baseline was signiﬁcantly LOWER in Responders (72  19
vs. 92  27 msec., p¼0.028), yet other parameters including renal/aorta ratio (RAR),
peak systolic velocity (PSV) or resistive index (RI) was not signiﬁcantly different be-
tween the groups (RAR, 3.7  1.7 vs. 3.7  1.9, p¼0.94; PSV, 218  94 vs. 214  91
cm/sec., p¼0.90; RI, 0.8  0.1 vs. 0.8  0.1, p¼0.56). Assessment of hormonal pa-
rameters suggested that either plasma renin activity (PRA), aldosterone concentration
(PAC) or BNP was not preoperative predictor for BP response to PTRA (PRA, 3.8 
5.3 vs. 2.5  4.9 ng/mL/h, p¼0.50; PAC, 79  29 vs. 56  38 pg/mL, p¼0.078; BNP,
80 75 vs. 178  200 pg/mL, p¼0.10). However, interestingly, baseline renal function
was signiﬁcantly worse in Responders (serum creatinine, 1.47  0.67 vs. 1.01  0.34
mg/dL, p¼0.021; eGFR, 36.0  21 vs. 52.4  22 mL/min/1.73m2, p¼0.037).
Conclusion: The present study demonstrated that ofﬁce BP did not represent patients’
daily hemodynamic status, and high 24-hour BP was a potent predictor for sufﬁcient
BP response to PTRA. These ﬁndings may help clinicians to optimize risk-beneﬁt
proﬁle of PTRA and reduce unnecessary intervention.
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Safety and Efﬁcacy of True Lumen Tracking Recanalization for the Chronic
Total Occlusions of Iliac and Femoral Artery
Rie Sugawara, Ren Kawaguchi, Yusuke Miyaishi, Hakuken Kan, Hiroshi Hoshizaki,
Shigeru Oshima
Gunma Prefectural Cardiovascular Center, Maebashi, Japan
Background: Chronic total occlusions(CTO) is still remains as one of the challenging
lesion in the ﬁeld of endovascular treatment(EVT). We aimed to investigate the safety
and efﬁcacy of EVT using true lumen tracking with 0.018 inch stiff guide wire for the
CTO of the iliac and femoral artery.
Methods: From January 2008 to July 2013, consecutive 70 CTO of iliac (n¼43) and
femoral arteries (n¼27) that performed EVT in our center were enrolled for this study.
True lumen tracking using with 0.018 inch stiff guide wire under intravascular
ultrasound(IVUS) guidance was attempted for all cases. The employment of bidi-
rectional approach was left to the operator0s decision. Procedure success which
deﬁned as residual stenosis less than 50% with Thrombolysis in Myocardial Infarc-
tion(TIMI) 3 ﬂow was investigated. The occurrence of thromboembolism and per-
forations related to procedure were investigated as the safety endpoint.
Results: TASC II TypeB/ C/ D were observed 31/ 5/ 34cases. Mean lesion length in iliac
lesion and femoral lesion was 72.6  37.7 mm and 78.0  30.7 mm respectively.
Bidirectional approach was performed for 27 cases. Successful guide wire crossing was
observed for 37 cases(86.0%) of iliac lesion and 22cases (81.5%) of femoral lesions.
Complete true lumen tracking was observed for 27cases (62.8%) of iliac lesion and
20cases (74.1%) of femoral lesions. No thromboembolism and one case of vessel
perforation after stenting were observed. Procedure success was achieved 37 cases
(86.0%) of iliac lesion and 22 cases (81.5%) of femoral lesions after further balloon
angioplasty or stenting. Univariate analysis showed that the heavy calciﬁcation at the CTO
site was signiﬁcantly related to guide wire crossing failure. (26.3% vs 3.1%:P¼0.009)
Conclusion: The true lumen tracking using with 0.018 inch stiff guide wire under
IVUS guidance seems have acceptable safety proﬁle and effective for successful
recanalization of CTO of iliac and femoral arteries./ORAL/Peripheral Vascular Intervention (Non-carotid, Non-neurovascular)
